Page 109 - MEGIN Book Of Abstracts - 2023
P. 109

University of Edinburgh, Edinburgh, UK; Laboratory of Cogni-  Diseases (DZNE), Rostock, Germany; Department of Psy-
            tive and Computational Neuroscience, Center for Biomedi-  chosomatic and Psychotherapeutic Medicine, University of
            cal Technology, Universidad Complutense and Universidad   Rostock, Rostock, Germany; Experimental Neuropsychophar-
            Politécnica de Madrid, Madrid, Spain; IRCCS San Giovanni di   macology, Federal Institute for Drugs and Medical Devices
            Dio Fatebenefratelli, Brescia, Italy; Memory Clinic and LANVIE   (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM),
            - Laboratory of Neuroimaging of Aging, University Hospitals   Bonn, Germany; Department of Neurosciences and Depart-
            and University of Geneva, Geneva, Switzerland; Department   ment of Neurology, Dokuz Eylül University Medical School,
            of Biophysics, International School of Medicine, Istanbul   Izmir, Turkey; Ann Romney Center for Neurologic Diseases,
            Medipol University, Istanbul, Turkey; Translational Neuro-  Harvard Medical School and Brigham and Women's Hospital,
            pharmacology, Department of Comparative Medicine, Yale   Boston, MA, USA; Janssen Research & Development, Janssen
            University School of Medicine, New Haven, CT, USA; Institute   Pharmaceutica NV, Beerse, Belgium; Vertex Pharmaceuticals
            of Memory and Alzheimer's Disease (IM2A), Department of   Incorporated, Boston, MA, USA
            Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de
            l'hôpital, Paris, France; Institut du Cerveau et de la Moelle   ABSTRACT Electrophysiology provides a real-time
            épinière, ICM, INSERM U1127, Sorbonne Université, Paris,   readout of neural functions and network capability in
            France; GRC n° 21, Alzheimer Precision Medicine (APM), AP-  different brain states, on temporal (fractions of mil-
            HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, Sorbonne   liseconds) and spatial (micro, meso, and macro) scales
            University, Paris, France; School of Computing, Electronics   unmet by other methodologies. However, current
            and Mathematics, Faculty of Science and Engineering, Plym-  international guidelines do not endorse the use of
            outh University, Plymouth, UK; School of Psychology, Univer-  electroencephalographic (EEG)/magnetoencephalo-
            sity of Glasgow, Glasgow, UK; Geriatric Psychiatry Division,   graphic (MEG) biomarkers in clinical trials performed in
            Centre for Addiction and Mental Health, Toronto, Ontario,   patients with Alzheimer's disease (AD), despite a surge
            Canada; Mentis Cura ehf, Reykjavík, Iceland; Department of   in recent validated evidence. This position paper of the
            Bio and Brain Engineering/Program of Brain and Cognitive   ISTAART Electrophysiology Professional Interest Area
            Engineering, Korea Advanced Institute of Science and Tech-  endorses consolidated and translational electrophysio-
            nology (KAIST), Daejeon, South Korea; Institute for Neurosci-  logical techniques applied to both experimental animal
            ence, Newcastle University, Newcastle upon Tyne, UK; IRCCS   models of AD and patients, to probe the effects of AD
            SDN, Napoli, Italy; Center of Neurosciences, Swammerdam   neuropathology (i.e., brain amyloidosis, tauopathy, and
            Institute of Life Sciences, University of Amsterdam, Amster-  neurodegeneration) on neurophysiological mecha-
            dam, The Netherlands; School of Psychological Sciences and   nisms underpinning neural excitation/inhibition and
            Health, University of Strathclyde, Glasgow, UK; Department   neurotransmission as well as brain network dynamics,
            of Neuroscience (DINOGMI), University of Genoa, Genoa,   synchronization, and functional connectivity, reflecting
            Italy; Clinica Neurologica, IRCCS Ospedale Policlinico San   thalamocortical and corticocortical residual capacity.
            Martino, Genoa, Italy; UC Davis Department of Neurology,   Converging evidence shows relationships between ab-
            Center for Neuroscience, Davis, CA, USA; Gladstone Institute   normalities in EEG/MEG markers and cognitive deficits
            of Neurological Disease, San Francisco, CA, USA; Department   in groups of AD patients at different disease stages. The
            of Pharmacology and Therapeutics, Trinity College Dublin,   supporting evidence for the application of electrophys-
            Dublin, Ireland; IRCCS San Raffaele Pisana, Rome, Italy; RIKEN   iology in AD clinical research as well as drug discovery
            Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-  pathways warrants an international initiative to include
            0198, Japan; Graduate School of Education, The University   the use of EEG/MEG biomarkers in the main multi-
            of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan;   centric projects planned in AD patients, to produce
            Advanced Center for Computing and Communication, RIKEN,   conclusive findings challenging the present regulatory
            2-1 Hirosawa, Wako 351-0198, Saitama, Japan; Faculty of   requirements and guidelines for AD studies.
            Physics, The University of Warsaw, Pasteur 5, 02-093 Warsaw,
            Poland; A. I. Virtanen Institute, University of Eastern Finland,   Keywords: Alzheimer's disease (AD), Electroencephalog-
            Kuopio, Finland; German Center for Neurodegenerative   raphy and magnetoencephalography (EEG and MEG),







             ontents         Index                       88
               C
   104   105   106   107   108   109   110   111   112   113   114